Tobramycin Alternatives Compared
| Tobramycin | Pulmozyme | Creon |
|
|---|
| Tobramycin | Pulmozyme (dornase alfa) | Creon (pancrelipase) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bacterial Infection, Bone infection, Cystic Fibrosis, Bacteremia, Burns - External, Endocarditis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Meningitis... View more |
Prescription only
Prescribed for Cystic Fibrosis. Pulmozyme may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Pancreatic Exocrine Dysfunction, Chronic Pancreatitis, Cystic Fibrosis. Creon may also be used for purposes not listed in this medication guide. |
Related suggestions Cystic Fibrosis
|
|||||||||||||||||||||||
| More about Tobramycin | More about Pulmozyme (dornase alfa) | More about Creon (pancrelipase) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Pulmozyme has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Creon has an average rating of 6.2 out of 10 from a total of 58 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: tobramycin side effects in more detail. |
See also: Pulmozyme side effects in more detail. |
See also: Creon side effects in more detail. |
||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
N/A |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all tobramycin prices |
View all Pulmozyme prices |
View all Creon prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Bethkis, Kitabis Pak, Tobi, TOBI Podhaler |
N/A |
Other pancrelipase brands include: Pancreaze, Pertzye, Viokace, Zenpep | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
3 hours |
11 hours |
N/A |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 187 drugs are known to interact with tobramycin:
|
A total of 1 drugs are known to interact with Pulmozyme:
|
A total of 26 drugs are known to interact with Creon:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
December 22, 1997 |
December 30, 1993 |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.